Komal Gurnani
Background and experience
Komal guides healthcare clients to innovate their strategy, research and development, and commercialization. She heads ZS’s pharma launch advisory team and our Global Immunology Center of Excellence.
Since joining ZS in 2011, she has worked extensively on global portfolio and launch strategies where she brings the blend of deep scientific focus along with robust customer-focused commercialization strategies to bear with her clients.
She has advised many clients on a range of topics including go-to-market strategy and launch differentiation in specialty pharma; commercial organizational design and integrated marketing (commercial, payer and patient); rare disease launch strategy and digitally enabled commercialization; prelaunch strategy and cross-functional unmet needs assessment (commercial, medical and market access); commercial operations optimization and portfolio cost efficiency; execution leadership on large immunology launches; and cross-functional coordination.
A recognized expert and thought leader across marketing advisory, launch planning, portfolio and brand planning, Komal regularly publishes on healthcare and pharma industry trends. She has supported 40+ clients across immunology, cardiology, respiratory, diabetes/metabolics, renal-hepatic and oncology.
Education
Global healthcare leaders executive program, Harvard Medical SchoolMBA, in strategy and marketing with a minor in finance, Indian School of Business, Hyderabad